A Randomized Phase I Study of a Hepatitis B Antigen Combined With IMP321

NCT00354861 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

BIOLOGICAL: hepatitis B antigen (without alum) plus IMP321
BIOLOGICAL: hepatitis B antigen alone (without alum)
BIOLOGICAL: Engerix B

Sponsor

Immutep S.A.S.

Collaborators

[object Object]